Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Concordia Healthcare Corp. T.CXR.R



TSX:CXR.R - Post by User

Comment by Lumberfeverlongon Sep 28, 2016 8:33am
149 Views
Post# 25284848

RE:RE:bad news, really bad news

RE:RE:bad news, really bad newsAssuming that the four drugs were actually purchased by Amco, this actually dispells the rumour that an additional $72M will be payable to Cinven since that finder's fee was due to if Concordia purchased specified drugs from a specified third party introduced by Cinven to Concordia.  If Cinven owned those drugs, how can a finder's fee be payable for Cinven introducing Concordia to itself?  Use your God given brains people.  Not to mention that it is completely ridiculaous that a finder's fee would be almost  three times the purchase price.A finder's fee is usually in the 1 to 2% range not 200 to 300% range.

Lemerson wrote:
TSX2016 wrote: https://www.medicines.org.uk/emc/PIL.29265.latest.pdf

Trazodone is actually bought from focus pharma and their address is the same as the headquater of AMOc. Longs are fxxxed.....More fees to pay to Cinven.


ummm Amco bought focus pharma in 2014


<< Previous
Bullboard Posts
Next >>